oral tirzepatide clinical trials Tirzepatide: First Approval | Drugs oral tirzepatide clinical trial results

There are now even more options available for patients who may be candidates for GLP-1 therapy

Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among some dermatologists who may also prescribe a teratogenic drug like isotretinoin for acne

Combining Ozempic and phentermine raises important safety questions

Semaglutide may reduce blood pressure through weight loss and direct vascular effects

After pulling its ALS drug Relyvrio from the market, Amylyx Pharmaceuticals is looking to target the GLP-1 space with the purchase of Eiger BioPharmaceuticals avexitide, which has been studied for the treatment of hyperinsulinemic hypoglycemia.

BPC-157 Canada research guide: top supplier comparison, COA standards, reconstitution math, and Health Canada compliance for 2026 lab work.